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Management of Nasal Silicone 
Granuloma
Ago Harlim
Abstract
The use of silicone as filler material has been banned by the FDA. Nevertheless, 
there are still some risks of using topical silicone, particularly cosmetic products 
that contain silicone. Bioavailability of silicone in skin tissues and long-term 
complications of silicone use in cosmetic products must be evaluated for safety 
reasons. Silicone can penetrate to the skin by injection. Because of economic issues 
and the rarity of medical grade silicone, various developing countries use industrial 
silicone, which results in even more complications. Patients with liquid silicone 
injected to their nose will usually visit a doctor after experiencing complication 
issues such as granuloma, edema, and redness with telangiectasia. Usually the 
patients want to remove the silicone and treat the complication. Unfortunately, 
silicone is difficult to be removed completely. Some complications are difficult to 
treat. To handle this complication issue, the doctor has to create a specific design 
of nose implant, perform curettage, or remove silicone and granuloma, and then a 
laser treatment and steroid injection will be performed.
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1. Introduction
Silicone injection has been used since 40 years ago, and at that time, many 
problems occurred such as migration, inflammation, and granuloma. In 1992, the 
FDA prohibited silicone injection for cosmetic use [1]. In addition to injection, 
silicone may be introduced into our body or skin through food intake and cosmetic. 
Silicone has been widely used in daily cosmetics. Nowadays, due to technology 
advances, topical drugs can pass through skin barrier and can be penetrated into 
the skin, which has become a great concern as it may induce granuloma formation. 
There are relatively very few studies that have been done on silicone concentration 
in the normal skin.
A study conducted by Harlim in 2018 found that a normal skin contained silicon. 
The study was performed by taking skin samples from normal subjects and those 
with face-lift procedure and subsequently compared those samples using the same 
criteria with the control group, which included skin samples of subjects that had 
received silicone injection, and the study found granuloma formation. The study 
found an average amount of silicon level of 44.07 ± 75.86 μg/g in patients with 
normal skin, while in patients with granuloma, they found 38 times greater silicon 
level (1709.21 ± 1851.72 μg/g) [2].
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2. Silicone
Injectable-grade silicone for medical use has been manufactured widely since 
the element has been known for its stable and inert characteristics [3, 4]. It includes 
the use of silicone oil, which has been utilized in the treatment of complicated 
retinal detachment and heavy silicone oil tamponade. The treatment seems to offer 
promising results, particularly on improving visual acuity as well as great results 
on some anatomical parameters; however, there are some concerns as it may cause 
several complications such as cataract, increased ocular pressure, heavy silicone oil 
emulsification, and mild inflammatory reaction [5–7].
Injectable-grade silicone has also been widely used in the form of silicone oil 
injection. Some studies have suggested that it may have an essential role in reduc-
ing the risk of developing diabetic foot ulcer due to its pressure-reducing proper-
ties; therefore, it can maintain plantar tissue thickness and alleviate symptoms of 
diabetic foot ulcer, which may be associated with foot biomechanics [8, 9].
Although it brings advantages, silicone injection may still develop some com-
plications, either local or systemic complications. Local complications may include 
formation of palpable nodule surrounding injection site, arthralgia, fatigue, 
electrical neuropathy, and electrical sensation [10], while systemic complications 
may also occur in the form of lymphadenopathy, renal disease, and hepatic dis-
ease. It indicates that the injected silicone can migrate from injection site to other 
organs causing local and systemic complications. An animal experimental study in 
mouse model may explain the pathogenesis of such complications. The study has 
demonstrated that macrophage of skin tissue may engulf the injected silicone and 
the silicone may be distributed through lymphatic circulation, ultimately causing 
accumulation in lymph nodes, adrenal glands, and the kidney, liver, and spleen as 
well as granuloma formation in the skin [11]. Complications due to silicone injec-
tion, particularly the granuloma formation may be dose-dependent. A study by 
Harlim has demonstrated that granuloma formation could be developed when there 
is a large amount of silicone exposure as the study only found a low level of silicone 
without any granuloma formation in the normal skin (Figure 1) [2].
Cultural changes have been encouraging people to pursue their passion on beauty 
and youth; therefore, cosmeticology has been rapidly growing. With technological 
advances, more mixed drug ingredients have been added to cosmetic products in 
order to beautify their customers. Thus, it may indirectly increase the use of topical 
Figure 1. 
The level of silicon (Si) in normal subjects who had never received silicone injection (never injected) and in 
subjects with granuloma who had received silicone injection. (cited from A Harlim, et all) [2].
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cosmetics that usually contain silicone; therefore, it will lead to increase silicone 
uptake to the skin. It has raised a concern that the prolonged and continuous use of 
cosmetics will cause granuloma formation and other chronic inflammatory effects.
3. Dietary intake and silicon
Aside from medical use, silicon has also been used in food industry, cosmetics, 
and pharmaceutical industries. Our data shows that the silicon levels in gastrointes-
tinal medications (e.g., antacids), mineral water, and soda drinks are 44.1, 25.6, and 
2.91 μg/g, respectively. It can be said that there are many routes for administering 
silicon into our body. The average daily intake of silicon for European and North 
American populations is 20–50 mg/day. In China and India, the daily intake of 
silicon is larger that may reach as many as 140–200 mg/day, in which wheats, fruits, 
and vegetables are the greatest producers [12].
A research institution of healthy aging and nutrition in the United Kingdom 
has recently reported a strong correlation between silicon in dietary intake and the 
health of bone and connective tissue. Therefore, it can be assumed that the correla-
tion is associated with collagen synthesis and/or stabilization of mineral matrix, i.e., 
silicone intake may affect bone density [13].
Another study, which is an animal experimental study, has demonstrated that 
there is no evidence of silicon accumulation in silicon consumption. Silicon can be 
eliminated through digestion process and can be found in feces (93–97%), urine 
(0.001–0.22%), and expired air (0.01–0.02%) [3]. It indicates that silicon is a stable 
element and at certain degree it can be resistant to digestive enzymes including gastric 
acid; therefore, it seems that silicon is not accumulated in the gastroinstestinal system.
4. Silicone in cosmetics
Beauty products for face, hair, and cosmetics may have high silicone content, 
in which it will be accumulated in the skin tissue. When a topical beauty product 
containing silicone is applied to the skin, the elastomeric particles of silicone will 
absorb various liquids including emollient and oil; therefore, silicone is used in skin 
care product as vehicle (carrier) of active ingredient for the skin or as oil control 
product of the skin [4, 5].
Types of silicone that are commonly used in cosmetic products:
• Dimethicone—clear, inert, liquid solubility depends on the length of polymer 
backbone ranging in thickness from watery consistency to thick.
• Dimethicone copolyol—silicone that contains an —OH group; therefore, it is 
more water-soluble resulting in easier incorporation into water-based formu-
lations and also reduces the “slip effect” of the silicone.
• Cyclomethicone—the shortest cyclic molecule, which has many similarities 
with dimethicone except it can evaporate, while dimethicone cannot.
• Cyclo-dimethicone—a combination of dimethicone and cyclomethicones.
The great use of silicones in cosmetic product may increase the risk of accumulation 
of the substance in our body, particularly in the facial skin. No clear evidence has been 
found on the bioavailability and concentration of accumulated silicone in topical uses.
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5. Granuloma: definition
Granuloma is a foreign body reaction against foreign substances that enter the 
skin. Granuloma occurs due to continuous or chronic inflammation against foreign 
substances. Silicone is a foreign substance in the body, which will be encapsulated 
by the body. Datia cells (giant cells) will encapsulate silicone material, and therefore 
inflammatory mediators cannot perform phagocytosis, which results in continuous 
inflammation and causes side effect. The encapsulated material has poor vascular-
ization; therefore, it may potentially induce infections [6].
6. Classification and etiology
There are many kinds of granuloma classification; however, the common classifica-
tions are those which have been adjusted to the etiologies [7, 8]. Granuloma formation 
may occur due to various factors such as biologic, chemical, and physical irritative 
agents [7]. Classification based on clinical, etiological, and histopathological features 
Infections Immunological aberration
Fungi Sarcoidosis
Histoplasma Crohn’s disease
Coccidioides Primary biliary cirrhosis
Blastomyces Giant cell arteritis
Sporothrix Peyronie’s disease
Aspergillus Hypogammaglobulinemia
Cryptococcus Langerhans’ granulomatosis
Hepatic granulomatous disease
Immune complex disease
Protozoa
Interferon-δ-receptor deficiency
Toxoplasma
Leishmania
Vasculitic granulomatosis
Metazoa Wegener’s
Toxocara Necrotizing sarcoidal
Schistosoma Churg-Strauss
Lymphomatoid
Spirochaetes Polyarteritis nodosa
T. Pallidum Bronchocentric
T. carateum Systemic lupus
T. pertune
Mycobacteria Leukocyte oxidase defect
M. tuberculosis Chronic granulomatous
M. leprae disease of childhood
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can be categorized further into infection, vasculitis, immunological aberration, leuko-
cyte oxidation deficiency, hypersensitivity, chemicals, or neoplasma [14, 15]. Table 1 
presents classification of granuloma based on etiology [8].
7. Silicone granuloma
Silicone granuloma is a foreign body granuloma, which is characterized by the 
presence of multinuclear Datia cells and macrophages surrounded by lymphocytes 
and infiltrates of neutrophils. The granulomatous histological lesion caused by 
silicone varies depending on the type of silicone.
Tissue reactions to silicone gel or liquids are characterized by the formation of 
silicone granuloma with cystic space containing foreign body [9]. The irregular 
surface of silicone cannot be phagocytosed completely by macrophage. Datia cells 
are formed due to “frustrated” macrophages. Microspheres in the size of less than 15 
Infections Immunological aberration
M. kansasii
M. marinum Hypersensitivity pneumonitis
M. avian Farmers’ lung
BCG vaccine Bird fanciers’
Mushroom workers’
Bacteria Suberosis (cork dust)
Brucella Bagassosis
Yersinia Maple bark strippers’
Paprika splitters’
Other infections Coffee bean
Cat-scratch Spatlese lung
Lymphogranuloma
Other
Neoplasia Fibrosing alveolitis
Carcinoma Whipple’s disease
Reticulosis Pyrexia of unknown origin
Pinealoma Radiotherapy
Dysgerminoma Cancer chemotherapy
Seminoma Panniculitis
Reticulum cell sarcoma Chalazion
Malignant nasal granuloma Sebacous cyst
Dermoid
Chemicals Sea urchin spine injury
Beryllium Tattoo
Zirconium Malakoplakia
Silica Blau’s syndrome
Starch
Table 1. 
Classification of granulomatous disorders (cited from James DG, Wiliams WL) [8].
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Figure 2. 
Results of histopathological examination (HE 400× magnification) in one of study subject. There is a Datia cell 
(arrow), which is phagocytosing silicone (S) and is trying to destroy it into smaller pieces (sk) [1].
Figure 3. 
Stadium 1, moderate reaction with a few inflammatory cells. Stadium 2, inflammatory cells with one or two 
Datia cells. Stadium 3, inflammatory cells with more than two Datia cells and <50% fibrotic area. Stadium 
4, inflammatory cells with more than two Datia cells and >50% fibrotic area. Stadium 5, inflammatory cells 
with one Datia cell and >50% fibrotic area. Stadium 6, <50% fibrotic area with no Datia cell. Stadium 7, >50% 
fibrotic area with no Datia cell. (cited from A Harlim, et all) [11].
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microns will be phagocytosed and transferred to the lymph node, while those with 
big size and nonabsorbable polymer will be encapsulated by fibrotic tissue [10].
Datia cell is essential in tissue response to silicone as seen in Figure 2, in which 
the Datia cell is phagocytosing the silicone. It appears that although the Datia cell 
cannot eliminate the silicone, it would produce fragmented silicone into smaller 
pieces. Within a month, the silicone will be in the size of 20–100 microns [11]. 
However, it still cannot be completely phagocytosed, and ultimately it will be 
encapsulated by fibrotic tissue.
In general, silicone granuloma can be categorized into three phases according to 
the natural history of our immune response, which are mild inflammatory phase, 
i.e., stage 1; inflammation with datia cells, i.e., stages 2, 3, 4, and 5; and tolerance 
phase with fibrosis, i.e., stages 6 and 7 (Figure 3).
According to Harlim in 2018, histopathological features of silicone granuloma 
can be categorized into seven stages, which are: [11]
Stadium 1, moderate reaction with a few inflammatory cells
Stadium 2, inflammatory cells with one or two Datia cells
Stadium 3, inflammatory cells with more than two Datia cells and <50% fibrotic area
Stadium 4, inflammatory cells with more than two Datia cells and >50% fibrotic area
Stadium 5, inflammatory cells with one Datia cell and >50% fibrotic area
Stadium 6, <50% fibrotic area with no Datia cell
Stadium 7, >50% fibrotic area with no Datia cell
8. Diagnosis
Granuloma is a form of localized nodular inflammation, which is found in 
tissues [7]. On examination, there is a tumor-like mass or node of granulation tissue 
with active fibroblast growth and capillaries that contain epithelial-like macro-
phages surrounded by mononuclear cells, lymphocytes, and sometime multinucle-
ated Datia cells present at the central core of granuloma [16].
On clinical point of view, silicone granuloma is characterized by the presence of 
complications of silicone. There are usually granuloma nodes, migrating silicone, 
wider nose, and signs of inflammation such as redness and swelling depending on 
the stage (Figure 4).
Figure 4. 
Granuloma due to nasal silicone injection. The photograph shows granuloma node, migrating silicone, wider 
nose, and signs of inflammation such as edema and redness.
Cosmetic Surgery
8
9. Management
The management of silicone-induced granuloma is often difficult due to migrating 
silicone and some of the silicone penetrating into the skin reaching the epidermis. In 
general, the management of granuloma can be categorized into two, i.e., surgical and 
pharmacological treatments. The management of nasal silicone granuloma is adjusted 
for the occurring complications. We must remove granuloma, which is under the 
skin; afterward, we perform excision of the excessive skin or implant insertion, creat-
ing a firmer and cosmetically more attractive skin. Remaining fibrosis or granuloma 
can be treated using steroid injection, and laser therapy is performed for redness.
10. Recommendation for surgical care
Granuloma formation occurs due to the presence of foreign body. Skin granu-
loma will cause a cosmetic problem; therefore, it should be removed.
11. Preoperative preparation
The preoperative preparation is similar to all kinds of skin surgery. A consulta-
tion prior to surgical procedure is necessary so that the doctor can perform both 
physical and psychological evaluation for the candidate. The patient should be 
informed about surgical procedure and the result may not be perfect as clean sili-
cone injection can never be performed and there is a possibility of swelling. Patients 
with extreme high expectation will file their complaints in the future.
During the consultation, we must find out about coagulation disorder, either 
primary or secondary, either due to medication of pharmacological treatment 
or supplementation. The patients are advised to avoid food or medication that 
may prolong the bleeding time within 1 or 2 weeks prior to the procedure such as 
anticoagulants, aspirin, ginseng, garlic, cod liver oil, anticholesterol agent, vitamin 
E, warfarin, and Ginkgo biloba.
Curettage procedure of nasal silicone granuloma is similar to skin graft procedure, 
in which the covering skin must be viable. On curettage, the skin will be thinner, and 
it can be necrotic if there is poor vascularization. Other issues that should come into 
our consideration are alcohol intake, smoking habit, metabolic disorder, and poor 
nutrition. Blood pressure and diabetes mellitus must be well-controlled [17–19].
12. Informed consent
When a skin surgeon decides to perform a surgical procedure, both doctor and 
patient must consequently understand the impact, risk, and advantages of the pro-
cedure. First, the doctor needs to explain the diagnosis and the procedure that will be 
performed. Treatment of nasal silicone injection is a combination of medical therapy 
and cosmetic procedure because when it is left untreated, there will be changes such 
as migration, granuloma, and continuous inflammation. The risks and the advantages 
of the procedure should be emphasized. Moreover, the procedure during the surgery 
and the expected result after surgery need to be explained. Possible risks that may 
develop such as infection and its prevention including the use of antibiotics must also 
be explained. Patients must know other probable risks such as bleeding, crooked nose, 
wound scar that probably occurs, asymmetrical nostrils, an implant impression on the 
skin, granuloma or fibrosis that cannot be cleaned up, persistent redness of skin color, 
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and other modalities of treatment that need to be carried out after the surgical proce-
dure. It should also be explained that the results probably may be imperfect, particularly 
for patients with unrealistic wish. Results of discussion and patient’s consent are written 
on an informed consent form, which is subsequently signed by the doctor and patient.
13. Technique and procedure
Every granuloma in the skin that causes cosmetic problem must be removed. 
Granuloma at inflammatory phase must also be removed to prevent the extension 
of inflammation. Local or general anesthesia could be used for procedures of skin 
excision, granuloma curettage, or installation of nasal implant. Instruments that 
must be prepared included minor surgery set, which can be equipped with curet-
tage kit for cases that need curettage.
14. Preoperative planning
The management of silicone-induced granuloma depends on the affected area; 
however, basically a doctor will first make a design planning. Next, the doctor will 
perform procedures according to the design or images and following the plan that 
has been discussed with the patient.
Depending on the occurring complication, we evaluate whether we need to 
remove the excessive skin from the nasal columella or should only perform curet-
tage and subsequently install a nasal implant.
Mark the area that will be excised and the protruding granuloma on the dorsal 
of the nose; therefore, during the surgery we emphasize on the location where the 
curettage will take place. If we plan to place a solid nasal implant, then we need to 
make a midline to ensure the implant stays straight when the swelling occurs due to 
anesthetic drugs.
Depending on the problem, when the nasal dorsum has become wider along 
with inflammation and the damaged skin, an elliptical vertical excision can be 
performed on it (Figure 5).
Figure 5. 
Elliptical excision of granuloma on the nasal skin.
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During silicone injection, it is common to have a wider and descending skin at 
the area of nasal columella due to migration of silicone injection, which always run 
downward from the nose; therefore, a skin excision can be performed at lateral and 
dorsal areas of the nasal columella (Figure 6).
15. Technique
After we have planned the management to overcome nasal problems, we subse-
quently transfer the plan into preoperative design images and subsequently perform 
an incision or excision following the plan.
16. Design of nasal implant
In some cases that require implants, the nasal implant is first carved before an 
excision is performed. Solid implant that has been commonly used is the L-shaped 
solid implant; however, other kinds of solid implant can also be used.
In making an implant, there are some guidelines on facial esthetics and architec-
tural balance that should be considered.
The face can be divided into three zones with identical width. The first includes 
a horizontal line from the hairline to the eyebrow; the second horizontal line is from 
the eyebrow to the nasal base and menton; and the third horizontal line is the line 
from the nasal base to the end border of the chin.
The association between the lips and chin should be evaluated. The chin projec-
tion is determined by a vertical line drawn from a point of one and a half ideal 
length of the nose to the part of vermillion of the upper lip. The lower lip cannot 
be more than 2 mm posterior to this line. The position of chin varies extremely 
depending on sex. In women, the position is slightly posterior to the lower lips, 
while in men the position of the chin is in-line (Figure 7) [20, 21].
The implant is carved or made prior to anesthetic procedure following the 
guidelines of architectural balance and problems of nasal silicone granuloma as well 
as the patient’s preferences. For nasal silicone granuloma cases, L-shaped nasal solid 
implant is used, and part of the nasal bridge is shaved so that it becomes slender 
since patients with granuloma due to silicone injection usually have wider nose and 
they want the nose become slender (Figure 3).
The height or the length of the implant is the midline border between the eye 
and eyebrow up to the nose. The crus of the implant must be measured following 
Figure 6. 
Design of excision procedure to remove the excessive skin at columella area.
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the base of columella to the nose. Usually, the crus is made straight so that it can 
elevate the descending skin caused by silicone injection (Figures 8 and 9).
Incision is always made on a hidden area and follows the contour of Langer’s 
line. The excision is made following preoperative design image, which is an ellipti-
cal excision on the nasal dorsum (Figure 5); the procedure is generally performed 
when the condition is very severe with inflammation and the skin is wrinkled 
and extremely wider. The risks of the procedure are the formation of thin vertical 
scar line on the nasal dorsum and dog-ear phenomenon at the end of excision. An 
accurate calculation before surgery is essential. It is suggested that the skin removal 
should not be too wide to prevent dog-ear phenomenon or we can place a nasal 
implant so that it seems firm and creates a better look. Excision can also be made 
on the area adjacent to excision cut in order to reduce granuloma around the lateral 
nose. The skin superior to the granuloma must be thick enough to maintain vascu-
larization and a viable skin. Many patients do not want any lengthy scar along their 
nose; therefore, the management of nasal silicone granuloma only includes curet-
tage, placement of implant, and excision of the excessive skin at columella area.
After the patient received anesthetics using lidocaine or xylocaine without adren-
alin, we perform a skin excision at the columella area and remove the excessive skin 
on the lateral and dorsal columella; afterwards, we perfom undermining procedure 
inferior to the granuloma using a curved clamp starting from the nasal dorsum area 
to the nasal bridge near the glabella and lateral of nose depending on the occurring 
problem. Next, curettage is performed to remove the granuloma. The skin superior 
Figure 7. 
Guidelines on measuring facial beauty and architectural balance.
Figure 8. 
L-shaped solid silicone implant. The edge is shaved so it becomes slender.
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to it must be thick enough and well-vascularized. In cases with remaining granuloma 
with thick fibrosis and those with difficulty in curettage, other modalities should be 
performed after surgical recovery period such as steroid injection.
To create a good-shaped nose, we remove the excessive skin at the columella 
area, and at the nasal bridge, we can place an implant so that the skin is firmer and 
the shape is cosmetically better. Nasal silicone implant is placed under the nasal skin 
at the curettage area, which has been previously occupied by silicone granuloma.
We can perform curettage to remove silicone and granuloma. In order to create a 
better superior nasal tip so that the nose seems straighter, we have two choices. The 
first choice is that we can place the implant under the skin, and at the area, the curet-
tage is performed; or we can put sutures at the lateral area of superior tip of the nose 
from lateral columella with opposite direction as presented in the following video.
17. Postoperative management
1. Use nasal splint or gauze for a week to prevent splint displacement.
2. Prescribing antibiotics for 5–7 days.
3. Prescribing analgetics every 4–6 hours as necessary.
4. Prescribing anti-inflammatory drugs for 5–7 days.
5. Normal saline solution for the nose to overcome postsurgical nasal 
congestion.
6. To reduce swelling, apply cold compress to periorbital within the first 
48 hours.
7. When sleeping, the patient should keep the head elevated approximately 45°.
Figure 9. 
Patients with silicone injection usually have wider columella area since liquid silicone will migrate downward 
due to gravity. Therefore, we have to remove the excessive skin of the lateral and the dorsal columella and place 
the implant to create a straight nose.
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8. If there is a seroma, we can remove it by suctioning using syringe during the 
follow-up visit.
9. Avoid any trauma for 2 weeks.
10. Remove the stitches on day 10–14.
11. Have a normal diet, but avoid foods that cause excess lip movement such as 
apples and corn on the cob for 2 weeks after surgery (Figure 10).
18. Adjunctive therapy to overcome other complications
The principle of therapy in managing patients with granuloma due to silicone injec-
tion is preventing the development of inflammation as it will cause extention of damage.
Evacuation of silicone-induced granuloma should be performed since the liquid 
silicone in the tissue is persistent and will continuously induce immune response. 
Although the granuloma has been excised, the remaining silicone, which has 
migrated to all direction and has been absorbed in the skin, cannot be removed, and 
therefore, it may cause recurrent granuloma. The remaining inflammation, both 
granuloma and fibrosis, requires further treatment.
For granuloma or fibrosis that cannot be removed by surgical procedure, other 
modalities are required to treat the remaining fibrosis and inflammation that can 
still be seen on the skin, i.e., skin redness and telangiectasia.
19. Fibrosis and remaining granuloma
Some case reports suggest that to treat silicone-induced granuloma, intralesion 
injection can be used as well as topical treatment of pimecrolimus, which is applied 
two times daily for 3 months. Topical imiquimod can be used for 8 weeks as well 
as minoxillin, allopurinol, and oral prednisone at the dose of 30 mg/day [22, 23]. 
Results of those treatment have not been satisfying although intralesion injection of 
triamsinolone is more significant for treating the occurring inflammation [24].
Granuloma and remaining fibrosis may also be treated with subdermal injection 
of triamcinolone acetonide at a dose of 10 mg/ml or a combination of triamcinolone 
acetonide and 5-fluorouracil. Steroid injection can be performed at the earliest 
within 2 weeks after wound closure.
The injection is performed once or twice weekly as many as five to seven times. 
The dose depends on the amount of remaining granuloma and fibrosis, and usually 
it is at dose of 0.2–0.4 cc per injection.
Figure 10. 
Patients with silicone injection usually have wider columella area (a). After the excessive skin of the lateral 
and the dorsal columella are removed and the implant is placed, the columella area will be more slender, thus 
shaping a straighter nose (b).
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Etanercept, which works on TNF-α receptor and Fc-IgG1 binding, has been 
reported providing good result for silicone granuloma [25–27]. The administration 
of this drug at the dose of 50 mg twice weekly or 25 mg of subcutaneous injection 
two times a week has offered relatively satisfying results [27].
20. Redness on the nasal skin
When the silicone has entered into the skin, it can cause granuloma due to 
chronic inflammation. Although the granuloma has been removed, the remain-
ing inflammation, e.g., redness on skin, still exists. One of them is redness due to 
neovascularization such as telangiectasia due to silicone block in the skin.
Nasal redness and telangiectasia can be reduced using laser treatment. To utilize 
laser for treatment, we need basic knowledge about the use of laser.
There are three characteristic properties of laser light: monochromatic light. 
The light contains only a single wavelength, which is determined by the magnitude 
of released energy. The light has coherent characteristic, and the photon moves 
regularly as it has the same wavefront to one another.
The light is highly directional. A laser light has a very tight beam that is dense, 
strong, and concentrated. The three abovementioned characteristics can be 
achieved since there is a process of stimulated emission.
A light is part of the spectrum of electromagnetic radiation with an energy 
known as photon, while the molecule that absorbs the light is called chromophore. 
The energy is transferred from photon entering into chromophore in the skin. After 
the energy is absorbed, the light can initiate photochemical reaction, heat up the 
tissue to the state of coagulation or evaporation, and can destroy or detonate tissue 
structure through extremely rapid localized heating.
Laser is an instrument that produces light beam with certain wavelength or 
color that is very parallel and coherent. The light wavelength is absorbed maximally 
by the component of the treated skin. When the absorption characteristics of the 
target tissue accurately meet the most ideal wavelength, it will develop maximum 
specificity of laser to tissue interaction.
The mechanism of action of laser is consistent with specific chromophore with 
certain wavelength. There are three major chromophores in the body, which are 
hemoglobin, pigment, and water. For redness and telangiectasia cases, we use laser, 
which mostly works on hemoglobin. The wavelength of laser must be adjusted 
to the existing problem. Laser light enters the target area on the skin, and subse-
quently the light is absorbed by specific blood vessel in the skin causing damage on 
the target blood vessel that contains hemoglobin without injuring the surrounding 
tissue. We need basic knowledge to perform safer use of laser [28, 29].
In addition to chromophore, we also need to know about thermal relaxation time 
(TRT). TRT is the time it takes for a target substance to cool half the temperature 
needed for heating the target without increasing the temperature of surrounding 
tissue. In order to perform safe procedure, the fluence of a laser pulse must be high 
enough to heat the target, and the pulse duration must be shorter than the TRT 
of the target. Each target has its own TRT. For blood vessel, which has TRT up to 
microseconds, we need long pulse duration; therefore, we should use the long-
pulse Nd:Yag laser instead of the QS Nd:Yag laser, which only has pulse duration of 
nanoseconds. QS Nd:Yag is usually used for tattoo removal.
Laser works based on the selective photothermolysis principle. In this case, it can 
be used for hemoglobin to treat redness due to the silicone injection. Some lasers 
that can also be used are vascular laser such as pulse dye laser (PDL) or long-pulse 
Nd:Yag [30, 31].
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A previous study shows that pulse dye laser (PDL) with a wavelength of 595 nm 
can be used for vascular disorder such as angioma, port-wine stain, rosacea, or 
other vascular disorders at the dose of 6–8 J/cm2 every 8 weeks. To prevent side 
effect, cooling is always performed before laser procedure; some instruments have 
already had a cryo cooler. The side effects of post-PDL laser treatment are bruis-
ing, crust, post-inflammatory hyperpigmentation, particularly for skin types 3–6 
according to Fitzpatrick classification [30].
Long-pulse Nd:Yag laser with a wavelength of 1064 nm is also good for treat-
ment of vascular disorder. For deeper vascular disorders and those abnormalities 
in patients with dark skin types such as the Fitzpatrick skin types 3–6, the instru-
ment will give greater advantages because the 1064 nm wavelength is usually used 
for pigment chromophore. In contrast, the instrument also has lower safety limit 
as poor cooling process can often burn the skin. Side effects of long-pulse Nd:Yag 
laser are bullae, crust, post-inflammatory hyperpigmenta-tion, and scar [31, 32].
In utilizing the long-pulse Nd:Yag laser, we need to set the pulse duration. In 
silicone-induced disorders, there will be redness on the skin, and one of them is 
telangiectasia that requires higher dose but lower pulse duration (Figure 11).
In erythematous skin cases, the long-pulse Nd:Yag laser with a wavelength of 
1064 nm, at dose of approximately 100 J, spot size of 4, and pulse duration of 10 ms, 
can be used. For telangiectasia, the power is approximately of 180 J, a spot size of 
2, and pulse duration of 5 ms. Sufficient cooling before and after laser procedure 
should be done, either by using ice pack, air cooling, cryo, or other methods. The 
laser treatment should be started at a low dose, and the dose is increased gradually 
for each visit until a change can be observed. The target does not diminish instantly; 
the color does not always change rapidly; sometimes it only becomes paler.
21. Pitfalls and the management
For a necrotic skin, skin excision on the nasal dorsum is usually done, which is 
followed by curettage of the surrounding area. We usually clean up the necrotic area 
and performed wound care, open wound healing enhanced with topical medication 
that can induce granulation, laser diode, PRP, or others. In general, the wound will 
heal in 2–3 months.
Figure 11. 
Illustration of a patient’s skin due to complication of silicone injection on the nasal skin; there is an 
erythematous skin, and among them, there is a telangiectasia (a). After Nd:Yag laser, the reddish skin and 
telangiectasia are reduced (b).
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Excessive granuloma or extensive fibrotic area occurs due to a hard necrotic skin, 
which creates difficulty in curettage. We can repeat the curettage procedure after 
a few months, which is followed by steroid injection. For less good-looking nose, 
excision procedure of the remaining skin can be repeated.
The skin can be burnt due to laser treatment for removing redness or telangiec-
tasia for nasal area. Sufficient cooling before and after laser procedure should be 
done immediately. Sometime a strong topical steroid such as clobetasol propionate 
can be applied directly onto the skin after the laser procedure.
22. Conclusion
Treatment for silicone-induced granuloma is not easy because the silicone that 
enters the skin can migrate and a lot of modalities are required to treat complica-
tions. Although the use of silicone injection has been prohibited, we still need to 
be cautious because there are many cosmetics containing silicone, especially with 
technological advances that can make the silicone readily absorbed by the skin.
© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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